Subscribe: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)(TM)
Preview: Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)(TM)

Libby's H*O*P*E* (*Helping *Ovarian Cancer Survivors *Persevere Through *Education)(TM)

An ovarian cancer resource dedicated to the support and empowerment of ovarian cancer survivors and their families through the principle that medical and educational "information is power" in the fight against ovarian cancer -- thereby allowing all surviv

Last Build Date: Fri, 29 Dec 2017 19:08:17 +0000


World Ovarian Cancer Day: Together We’re StrongerpaulcWOCD.05.08.14WOCDLate_Diagnosis_large1-980x600

Tue, 05 May 2015 22:04:18 +0000

Each year, nearly a quarter of a million women around the world are diagnosed with ovarian cancer and the disease is responsible for 140,000 deaths annually. Statistics show that just 45% of women with ovarian cancer are likely to survive for five years compared with 89% of women with breast cancer. We ask that you join us […](image) (image)

Media Files:

A Way to Kill Chemo-Resistant Ovarian Cancer Cells: Cut Down Their ProtectorGosProtein_GSN_PDB_1c0fpaulcProtein Data Base 3-D rendering of the Gelsolin protein. (Photo: Wikipedia)tsang_benShieh

Thu, 25 Sep 2014 19:02:30 +0000

A recent study provides new insight into why ovarian cancer is often resistant to chemotherapy, as well as a potential way to improve its diagnosis and treatment. Ovarian cancer is the most lethal gynecological cancer, claiming the lives of more than 60% of women who are diagnosed with the disease. A study involving Ottawa and […](image) (image)

Media Files:

Stanford Researchers Create “Evolved” Protein That May Stop Breast & Ovarian Cancers From Spreadingstanford metastasis_newspaulcstanford metastasis_newsProfessor, Molecular Neurobiology Laboratory, Françoise Gilot-Salk Chair

Wed, 24 Sep 2014 15:57:30 +0000

 Early but promising tests in lab mice suggest that a bioengineered protein therapy, administered intravenously, may halt the spread of breast and ovarian cancers from their original tumor sites. Mice with ovarian cancer had a 90 percent reduction in metastatic nodules when treated with the engineered decoy protein. This approach might one day provide an […](image) (image)

Media Files:

Role For Gemcitabine As Second-line Chemotherapy in Recurrent Clear Cell Ovarian Cancerclear cell carcinomapaulcClear Cell Carcinoma of the OvaryMaurie Markman, M.D.

Sun, 21 Sep 2014 22:09:08 +0000

In a recent 2014 retrospective analysis involving 72 recurrent ovarian clear cell patients who underwent second-line therapy at one of 20 Italian centers over a 16-year period, the researchers noted that a small subgroup of patients who received the drug gemcitabine (Gemzar®) appeared to have a higher rate of tumor response, as compared to women […](image) (image)

Media Files:

Dana Farber Webchat: The Latest in Ovarian Cancer Treatment & Researchmatulonis, ursulapaulc

Sat, 20 Sep 2014 19:20:33 +0000

The latest in ovarian cancer treatment and research is addressed via a Dana-Farber Cancer Institute webchat that was conducted live on September 16, 2014.(image) (image)

Media Files:

Improved Survival of Ovarian Cancer Patients Receiving Treatment Guided by Comprehensive Tumor ProfilingDNA Double Helix StructurepaulcProfessor Hani GabraGilda Witte, CEO of Ovarian Cancer ActionAndreas Voss

Fri, 19 Sep 2014 23:07:38 +0000

Data from an ovarian cancer registry presented at the 2014 European Society for Gynaecological Oncology (ESGO) annual meeting reinforce comprehensive tumor profiling as a “game changer” for oncologists.(image) (image)

Media Files:

WIH Researchers Examine Role of Hormone HE4 in Patient Responses to Ovarian Cancer TreatmentMoore_Richardpaulc

Fri, 19 Sep 2014 04:33:55 +0000

Researchers at Women & Infants’ Hospital of Rhode Island recently published the results of an investigation into the role of hormone HE4 in patient responses to ovarian cancer treatment.(image) (image)

Media Files:

SU2C Announces the Formation of a New Translational Research Ovarian Cancer “Dream Team”paulcstanduptocancerbannerOCRFOCNA1NOCC - Logo

Sat, 06 Sep 2014 02:32:56 +0000

Ovarian Cancer Community Joins Forces to Fight Deadliest Gynecologic Cancer. The New Stand Up To Cancer Dream Team Will Launch in 2015. The Ovarian Cancer Research Fund, The Ovarian Cancer National Alliance, and the National Ovarian Cancer Coalition Team Up to Fund New Translational Research Ovarian Cancer “Dream Team.”   A groundbreaking collaboration is underway among three […](image) (image)

Media Files:

U.S. President Barack Obama Proclaims September 2014 As National Ovarian Cancer Awareness Month — What Should You Know?paulcWhiteHouse-Logodidyouknowbeatlogo_308x196obama_signing

Sat, 30 Aug 2014 02:11:52 +0000

Today, U.S. President Barack Obama designated September 2014 as National Ovarian Cancer Awareness Month. “This month, our Nation stands with everyone who has been touched by this disease, and we recognize all those committed to advancing the fight against this cancer through research, advocacy, and quality care. Together, let us renew our commitment to reducing […](image) (image)

Media Files:

National Women’s Health Week — Learn, Spread the Word & Join!paulcNWHW1 logoNWHW_bannerinfographicNWHW-infographic-well-woman-visit

Mon, 12 May 2014 17:59:15 +0000

National Women’s Health Week begins on Mother’s Day each year. During this week, individuals, families, communities, and others work to help women learn how to achieve longer, healthier, and safer lives. Beginning with Mother’s Day on Sunday, May 11, we celebrate National Women’s Health Week by encouraging the women in our lives – our mothers, […](image) (image)

Media Files:

Glutamine Ratio is Key Ovarian Cancer IndicatorpaulcDeepak NagrathRice University ResearchersLifeng

Sat, 10 May 2014 21:58:01 +0000

Glutamine plays an important role in cellular growth in several cancers. A Rice University-led study shows how ovarian cancer metabolism changes between early and late stages. In this study, a further link between glutamine dependency and tumor invasiveness is established in ovarian cancer. A Rice University-led analysis of the metabolic profiles of hundreds of ovarian tumors […](image) (image)

Media Files:

Ovarian Cancer Cells Are More Aggressive On Soft TissuespaulcModel Release-YES

Fri, 09 May 2014 16:15:42 +0000

When ovarian cancer spreads from the ovaries it almost always does so to a layer of fatty tissue that lines the gut. A new study has found that ovarian cancer cells are more aggressive on these soft tissues due to the mechanical properties of this environment. The finding is contrary to what is seen with […](image) (image)

Media Files:

World Ovarian Cancer Day: One Voice for Every WomanpaulcWOCD_Sharable_Graphic_square_2014WOCDLate_Diagnosis_large1-980x600

Thu, 08 May 2014 16:41:08 +0000

Each year, nearly a quarter of a million women around the world are diagnosed with ovarian cancer and the disease is responsible for 140,000 deaths annually. Statistics show that just 45% of women with ovarian cancer are likely to survive for five years compared with 89% of women with breast cancer. We ask that you join us […](image) (image)

Media Files:

Broadway Star Valisia LeKae Debuts Ovarian Cancer PSA in Times Squarepaulc

Thu, 01 May 2014 23:29:00 +0000

 “God has given me another role to play and like all my previous roles, I plan to go all in, only this time I plan to Win!” — Broadway star Valisia LeKae Broadway star Valisia LeKae is a 2013 Tony Award nominee for “Best Actress in a Musical” for her performance as Diana Ross in […](image) (image)

Media Files:

Dana-Farber Oncologists Differ Widely on the Use of Multiplex Tumor Genomic Testingpaulc

Wed, 26 Mar 2014 23:35:48 +0000

A new study by researchers at the Dana-Farber Cancer Institute suggests that not all doctors are ready to embrace tests that may identify hundreds of genomic changes in a patient’s tumor sample for the purpose of determining appropriate treatment. Many cancer researchers believe that cutting-edge advances in genomics will pave the way for personalized or “precision” cancer […](image) (image)

Media Files: